Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

You are here

Clinical Preventive Services

Latest Data

Explore the latest data and disparities for each indicator.

View data for C-16 in DATA2020
View data for HDS-12 in DATA2020
View data for D-5.1 in DATA2020

FileDownload the latest C-16 and IID-8 data in spreadsheet format [XLSX - 30KB]

Where We’ve Been and Where We’re Going

From 2008 to 2018, the percentage of adults aged 50–75 years receiving a colorectal cancer screening based on the most recent guidelines increased 25.1%, from 52.1% to 65.2% (age adjusted).

Between 2005-08 and 2013–16, the change in blood pressure control among adults aged 18 years and over with hypertension was not statistically significant (41.3% in 2005-08 and 47.8% in 2013-16, age adjusted). In 2013–16, several population groups with hypertension had the highest rate of blood pressure control in selected demographic categories, including non-Hispanic white persons, women, and those with activity limitations, public health insurance, or diabetes.

Between 2005–08 and 2013–16, the change in the rate of poor glycemic control (HbA1c greater than 9%) among adults aged 18 years and over with diagnosed diabetes was not statistically significant (18.0% in 2005–08 and 18.7% in 2013–16, age adjusted).

Between 2012 and 2018, the change in the percentage of children aged 19–35 months who have received the recommended doses of DTaP, polio, MMR, Hib, Hep B, varicella, and PCV vaccines increased 6.4%, from 68.4% to 72.8%. Several population groups had the highest vaccination rate in selected demographic categories, including children of mothers with an advanced degree and those with family incomes 600% or more of the poverty threshold, or private health insurance.

Colorectal Cancer Screening (C-16)

  • Healthy People 2020 objective C-16 tracks the proportion of adults aged 50–75 years who have received a colorectal cancer screening based on the most recent guidelines.
    • HP2020 Baseline: In 2008, 52.1% of adults aged 50–75 years received a colorectal cancer screening based on the most recent guidelines (age adjusted).
    • HP2020 Target: 70.5%, by modeling/projection.
    • Most Recent: In 2018, 65.2% of adults aged 50–75 years received a colorectal cancer screening based on the most recent guidelines (age adjusted).
  • Among racial and ethnic groups, the non-Hispanic white population had the highest rate of colorectal cancer screening based on the most recent guidelines, 67.6% of adults aged 50–75 years (age adjusted) in 2018. Rates for other racial and ethnic groups were:
    • 56.5% among American Indian or Alaska Native adults aged 50–75 years; the best group rate was 19.5% higher
    • 57.1% among Asian adults aged 50–75 years; the best group rate was 18.5% higher
    • 57.7% among Hispanic adults aged 50–75 years; the best group rate was 17.2% higher
    • 63.9% among non-Hispanic black adults aged 50–75 years; the best group rate was 5.8% higher
  • In 2018, there was no statistically significant difference between women and men aged 50–75 years who had received a colorectal cancer screening based on the most recent guidelines (64.8% versus 65.7%, age adjusted) .
  • Among education groups for persons aged 50–75 years, those with an advanced degree had the highest rate of colorectal cancer screening based on the most recent guidelines, 74.8% (age adjusted) in 2018. Rates for other education groups were:
    • 51.3% among those with less than a high school education; the best group rate was 45.9% higher
    • 61.6% among those with a high school education or GED; the best group rate was 21.5% higher
    • 67.5% among those with some college education; the best group rate was 10.8% higher
    • 64.6% among those with an associate’s degree; the best group rate was 15.8% higher
    • 70.3% among those with a 4-year college degree; the best group rate was 6.3% higher
       
  • Among income groups for persons aged 50–75 years, those with family incomes 600% or more of the poverty threshold had the highest rate of colorectal cancer screening based on the most recent guidelines, 74.3% (age adjusted) in 2018. Rates for other income groups were:
    • 53.2% among those with family incomes under the poverty threshold; the best group rate was 39.6% higher
    • 55.4% among those with family incomes 100% to 199% of the poverty threshold; the best group rate was 34.2% higher
    • 61.8% among those with family incomes 200% to 399% of the poverty threshold; the best group rate was 20.2% higher
    • 68.7% among those with family incomes 400% to 599% of the poverty threshold; the best group rate was 8.1% higher
  • In 2018, persons aged 50–64 years with private health insurance had the highest rate of colorectal cancer screening based on the most recent guidelines, 64.3%, among insurance groups. Those with public insurance and the uninsured had rates of 61.6% and 29.7%, respectively. The rate for those with private health insurance was more than twice that for the uninsured population. There was no statistically significant difference between those with private and public insurance. 
     

Persons Receiving a Recommended Colorectal Cancer Screening by Insurance Status, 2018

WG1

Data source: National Health Interview Survey (NHIS), CDC/NCHS.

Endnotes:

  • Unrounded values with additional decimal places beyond what are shown here are used in calculating health disparities, including identifying the best group and calculating the differences between groups. Rounded values displayed here are used in calculating changes over time and percent change needed to meet the target.
  • Unless otherwise specified, all differences described are statistically significant at the 0.05 level of significance using a 1-sided test for disparities and a 2-sided test for trends.
  • Data (except those by health insurance status) are age adjusted to the 2000 standard population using the age groups 50–64 and 65–75 years. Data by health insurance status are not age adjusted. Age-adjusted rates are weighted sums of age-specific rates.
  • Data for this measure are available periodically and come from the National Health Interview Survey (NHIS), CDC/NCHS.
  • U.S. Preventive Services Task Force guidelines recommend screening for colorectal cancer using fecal occult blood testing annually, sigmoidoscopy every 5 years with fecal occult blood testing every 3 years, or colonoscopy every 10 years for persons aged 50–75 years.

Back to Top

Blood Pressure Control (HDS-12)

  • Healthy People 2020 objective HDS-12 tracks the proportion of adults with hypertension whose blood pressure is under control (systolic blood pressure <140 mm Hg and diastolic blood pressure <90 mm Hg).
    • HP2020 Baseline: In 2005–08, 43.7% of adults aged 18 years and over with hypertension had it under control (age adjusted).
    • HP2020 Target: 61.2%, a 40% improvement over the baseline.
    • Most Recent: In 2013-16, 47.8% of adults aged 18 years and over wth hypertension had their blood pressure under control (age adjusted).
  • Among racial and ethnic groups, the non-Hispanic white population had the highest rate of blood pressure control, 51.7% of adults aged 18 years and over with hypertension (age adjusted) in 2013–16. Rates (age adjusted) for other racial and ethnic groups were:
    • 34.7% among non-Hispanic Asian adults; the best group rate was 49.1% higher
    • 41.5% among non-Hispanic black adults; the best group rate was 24.4% higher
    • 43.3% among Hispanic or Latino adults; the best group rate was 19.3% higher
  • Women aged 18 years and over with hypertension had a 34.8% higher (better) rate of blood pressure control than men (56.3% versus 41.8%, age adjusted) in 2013–16.
  • Adults aged 20 years and over with hypertension with activity limitations had an 18.8% higher (better) rate of blood pressure control than persons without activity limitations (54.4% versus 45.8%, age adjusted) in 2013–16.

Controlled High Blood Pressure by Sex, 2013–2016

Women aged 18 years and over with hypertension had a 34.8% higher (better) rate of high blood pressure control than men.

Data source: National Health and Nutrition Examination Survey (NHANES), CDC/NCHS.

  • Among broad age groups, adults aged 45–64 years with hypertension had the highest rate of blood pressure control, 55.3% in 2013–16. Rates for other age groups were:
    • 42.3% among adults aged 18–44 years; the best group rate was 30.8% higher
    • 49.7% among adults aged 65 years and over; the best group rate was 11.2% higher
  • When further refining the age groups, adults aged 55–64 years with hypertension had the highest rate of blood pressure control, 59.4% in 2013–16. Rates for other age groups were:
    • 43.9% among adults aged 25–44 years; the best group rate was 35.2% higher
    • 49.1% among adults aged 45–54 years; the best group rate was 21.1% higher
    • 55.1% among adults aged 65–74 years; not significantly different than the best group rate
    • 44.8% among adults aged 75–79 years; the best group rate was 32.6% higher
    • 40.8% among adults aged 80 years and over; the best group rate was 45.8% higher
  • Adults aged 18 years and over with hypertension who were born in the U.S. had a 24.6% higher rate of blood pressure control than persons born outside the U.S. (49.2% versus 39.5%, age adjusted) in 2013–16.
  • Among health insurance status groups, adults aged 18–64 years with hypertension with public health insurance had the highest rate of blood pressure control, 55.3% (age adjusted) in 2013–16, whereas persons with private insurance had a rate of 50.0% (not significantly different than the best group rate) and persons with no health insurance had a rate of 30.9%. The rate for persons with public health insurance was 79.1% higher than that for persons with no health insurance.
  • In 2011–14, adults aged 18 years and over with hypertension and diabetes had a 17.0% higher (better) rate of blood pressure control than those without diabetes (54.1% versus 46.3%, age adjusted).

Endnotes:

  • Unrounded values with additional decimal places beyond what are shown here are used in calculating health disparities, including identifying the best group and calculating the differences between groups. Rounded values displayed here are used in calculating changes over time and percent change needed to meet the target.
  • Unless otherwise specified, all differences described are statistically significant at the 0.05 level of significance using a 1-sided test for disparities and a 2-sided test for trends.
  • Data for this measure are available biennially and come from the National Health and Nutrition Examination Survey (NHANES), CDC/NCHS. Preferably 4 years of data are pooled for analysis when available.
  • The terms “Hispanic or Latino” and “Hispanic” are used interchangeably in this report.
  • Data (except those by disability status, education status, health insurance coverage, obesity status, and age group) are age adjusted to the 2000 standard population using the age groups 18–49, 50–59, 60–69, 70–79, and 80 years and over. Data by disability and obesity status are adjusted using the age groups 20–49, 50–59, 60–69, 70–79, and 80 years and over. Data by education status are adjusted using the age groups 25–49, 50–59, 60–69, 70–79, and 80 years and over. Data by health insurance coverage are adjusted using the age groups 18–49, 50–59, and 60–64 years. Data by age group are not age adjusted. Age-adjusted rates are weighted sums of age-specific rates.
  • Blood pressure control is defined as an average systolic blood pressure <140 mm Hg and an average diastolic blood pressure <90 mm Hg among adults with hypertension. Hypertension is defined as an average systolic blood pressure ≥140 mm Hg, an average diastolic blood pressure ≥90 mm Hg, or self-reported current use of blood pressure–lowering medication. Pregnant women are excluded from analyses.
     

Back to Top

Poor Glycemic Control (D-5.1)

  • Healthy People 2020 objective D-5.1 tracks the proportion of adults with diagnosed diabetes who have poor glycemic control (HbA1c greater than 9%).
    • HP2020 Baseline: In 2005–08, 18.0% of adults aged 18 years and over with diagnosed diabetes had poor glycemic control (age adjusted).
    • HP2020 Target: 16.2%, a 10% improvement over the baseline.
    • Most Recent: In 2013–16, 18.7% of adults aged 18 years and over with diagnosed diabetes had poor glycemic control (age adjusted).
  • Among racial and ethnic groups in 2013–16, the non-Hispanic white population had the lowest (best) rate of poor glycemic control, 11.0% of adults aged 18 years and over with diagnosed diabetes (age adjusted). Rates (age adjusted) for other racial and ethnic groups were:
    • 28.3% among the Hispanic population; more than 2.5 times the best group rate
    • 24.3% among the non-Hispanic black population; more than twice the best group rate
  • Persons with diagnosed diabetes aged 65 years and over had the lowest rate of poor glycemic control among broad age groups, 7.5% in 2013–16. Rates for other age groups were:
    • 18.7% among persons aged 45–64 years; 2.5 times the best group rate
    • 20.8% among persons aged 18–44 years; more than 2.5 times the best group rate

Poor Glycemic Control by Age, 2013–2016

WG 3.jpg

Data source: National Health and Nutrition Examination Survey (NHANES), CDC/NCHS.

  • Adults aged 20 years and over with diagnosed diabetes who had activity limitations had a lower rate of poor glycemic control compared to adults without activity limitations (14.0% versus 20.5%, age adjusted) in 2013–16. The rate for adults without activity limitations was 46.6% higher than that for adults with activity limitations.
  • Adults aged 18–64 years with diagnosed diabetes who had health insurance had a lower rate of poor glycemic control compared to adults who did not have health insurance (17.3% versus 35.3%, age adjusted) in 2013–16. The rate for adults without health insurance was twice that for adults with health insurance.
  • Comparisons for 2013–16 among sex, country of birth, and obesity status groups were not statistically significant.

Endnotes:

  • Unrounded values with additional decimal places beyond what are shown here are used in calculating health disparities, including identifying the best group and calculating the differences between groups. Rounded values displayed here are used in calculating changes over time and percent change needed to meet the target.
  • Unless otherwise specified, all differences described are statistically significant at the 0.05 level of significance using a 1-sided test for disparities and a 2-sided test for trends.
  • Data for this measure are available biennially and come from the National Health and Nutrition Examination Survey (NHANES), CDC/NCHS. Preferably 4 years of data are pooled for analysis when available.
  • The terms “Hispanic or Latino” and “Hispanic” are used interchangeably in this report.
  • Data (except those by education status, health insurance coverage, obesity status, marital status, disability status, and age group) are age adjusted to the 2000 standard population using the age groups 18–49, 50–59, 60–69, 70–79, and 80 years and over. Data by education status are adjusted using the age groups 25–49, 50–59, 60–69, 70–79, and 80 years and over. Data by health insurance coverage are adjusted using the age groups 18–49, 50–59, and 60–64 years. Data by obesity status, disability status, and marital status are age adjusted using the groups 20–49, 50–59, 60–69, 70–79, and 80 years and over. Data by age group are not age adjusted. Age-adjusted rates are weighted sums of age-specific rates.
  • Diagnosed diabetes is self-reported based on the question “Have you ever been told by a doctor or other health professional that you have diabetes or sugar diabetes?” Women who reported having diabetes only during pregnancy and persons who reported being diagnosed as having “borderline” diabetes are excluded. Women who are pregnant at the time of the exam are also excluded.
     

Back to Top

Fully Immunized Children (IID-8)

  • Healthy People 2020 objective IID-8 tracks the proportion of children aged 19–35 months who have received the recommended doses of diphtheria, tetanus, and pertussis (DTaP); polio; measles, mumps, and rubella (MMR); Haemophilus influenzae type b (Hib); hepatitis B (Hep B); varicella; and pneumococcal conjugate vaccine (PCV) vaccines.
    • HP2020 Baseline: In 2012, 68.4% of children aged 19–35 months had received the recommended doses of DTaP, polio, MMR, Hib, Hep B, varicella, and PCV vaccines.
    • HP2020 Target: 80.0%, consistent with national programs.
    • Most Recent: In 2018, 72.8% of children aged 19–35 months had received the recommended doses of DTaP, polio, MMR, Hib, Hep B, varicella, and PCV vaccines.
  • Among racial and ethnic groups, Native Hawaiian or Other Pacific Islander children aged 19–35 months had the highest rate of receiving all recommended vaccinations, 85.2% in 2018. Rates for other racial and ethnic groups were:
    • 67.9% for non-Hispanic black children; the best group rate was 25.5% higher
    • 70.4% for Hispanic children; the best group rate was 21.0% higher
    • 73.6% for Asian children; the best group rate was 15.8% higher
    • 74.2% for children of 2 or more races; the best group rate was 14.9% higher
    • 75.0% for non-Hispanic white children; the best group rate was 13.6% higher
  • In 2018, there was no statistically significant difference between boys and girls aged 19–35 months (72.5% versus 73.1%) who had received all recommended vaccinations. 
  • In 2018, children aged 19–35 months of mothers aged 25 years and over with an advanced degree had the highest rate of receiving all recommended vaccinations (82.2%) among education groups. Rates for children of mothers 25 years and over with other educational attainment levels were:
    • 67.9% for children of mothers with less than a high school education; the best group rate was 21.1% higher
    • 69.4% for children of mothers with a high school education; the best group rate was 18.4% higher
    • 72.6% for children of mothers with some college education; the best group rate was 13.3% higher
    • 72.8% for children of mothers with an associate’s degree; the best group rate was 12.9% higher
    • 76.0% for children of mothers with a 4-year college degree; the best group rate was 8.1% higher
  • Children aged 19–35 months in families with incomes 600% or more of the poverty threshold had the highest rate of receiving all recommended vaccinations (82.3%) among income groups in 2018. Rates for children in other income groups were:
    • 66.6% for those with family incomes below the poverty threshold; the best group rate was 23.7% higher
    • 67.4% for those with family incomes between 100% and 199% of the poverty threshold; the best group rate was 22.1% higher
    • 73.9% for those with family incomes between 200% and 399% of the poverty threshold; the best group rate was 11.4% higher
    • 81.5% for those with family incomes between 400 and 599% of the poverty threshold; not significantly different from the best group rate
  • Children aged 19–35 months with private health insurance had the highest rate of receiving all recommended vaccinations (77.0%) among insurance groups in 2018. Rates for children in other insurance groups were:
    • 52.5% for those without health insurance; the best group rate was 46.8% higher
    • 68.4% for those with public insurance; the best group rate was 12.6% higher

Children Receiving All Recommended Vaccinations by Insurance Status, 2018

The rate for children aged 19-35 months with private health insurance was 46.8% higher than the rate for those without health insurance.

Data source: National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS.

Endnotes:

  • Unrounded values with additional decimal places beyond what are shown here are used in calculating health disparities, including identifying the best group and calculating the differences between groups. Rounded values displayed here are used in calculating changes over time and percent change needed to meet the target.
  • Unless otherwise specified, all differences described are statistically significant at the 0.05 level of significance using a 1-sided test for disparities and a 2-sided test for trends.
  • Data for this measure are available annually and come from the National Immunization Survey (NIS), CDC/NCIRD.
  • Public and private insurance are not mutually exclusive. About 5% of children with health insurance are included in both categories.
  • Recommended vaccination is defined as receipt of the following doses of each of the following vaccines: 4 DTaP, 3 polio, 1 MMR, 3 or 4 Hib (depending on product type received, including primary series plus the booster dose), 3 Hep B, 1 varicella, and 4 PCV.

Back to Top